nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—ABCB1—melanoma	0.168	1	CbGaD
Fluvoxamine—CYP1A1—Dacarbazine—melanoma	0.0906	0.154	CbGbCtD
Fluvoxamine—CYP2E1—Dacarbazine—melanoma	0.07	0.119	CbGbCtD
Fluvoxamine—CYP1A2—Carmustine—melanoma	0.0668	0.114	CbGbCtD
Fluvoxamine—CYP1A2—Vemurafenib—melanoma	0.0528	0.0899	CbGbCtD
Fluvoxamine—CYP3A4—Temozolomide—melanoma	0.0505	0.0859	CbGbCtD
Fluvoxamine—CYP2D6—Vemurafenib—melanoma	0.0435	0.074	CbGbCtD
Fluvoxamine—CYP1A2—Dacarbazine—melanoma	0.0405	0.0689	CbGbCtD
Fluvoxamine—CYP3A7—Docetaxel—melanoma	0.0324	0.0552	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0324	0.0552	CbGbCtD
Fluvoxamine—ABCB1—Dactinomycin—melanoma	0.0307	0.0522	CbGbCtD
Fluvoxamine—CYP3A4—Vemurafenib—melanoma	0.0277	0.0471	CbGbCtD
Fluvoxamine—CYP3A5—Docetaxel—melanoma	0.0243	0.0414	CbGbCtD
Fluvoxamine—ABCB1—Docetaxel—melanoma	0.0158	0.027	CbGbCtD
Fluvoxamine—CYP3A4—Docetaxel—melanoma	0.00949	0.0162	CbGbCtD
Fluvoxamine—Dizziness—Vemurafenib—melanoma	0.000277	0.00146	CcSEcCtD
Fluvoxamine—Alopecia—Carmustine—melanoma	0.000275	0.00146	CcSEcCtD
Fluvoxamine—Angiopathy—Temozolomide—melanoma	0.000273	0.00144	CcSEcCtD
Fluvoxamine—Mental disorder—Carmustine—melanoma	0.000273	0.00144	CcSEcCtD
Fluvoxamine—Ataxia—Docetaxel—melanoma	0.000272	0.00144	CcSEcCtD
Fluvoxamine—Malnutrition—Carmustine—melanoma	0.000271	0.00143	CcSEcCtD
Fluvoxamine—Cough—Bleomycin—melanoma	0.000271	0.00143	CcSEcCtD
Fluvoxamine—Chills—Temozolomide—melanoma	0.00027	0.00143	CcSEcCtD
Fluvoxamine—Dehydration—Docetaxel—melanoma	0.000269	0.00142	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Dactinomycin—melanoma	0.000269	0.00142	CcSEcCtD
Fluvoxamine—Anaemia—Dactinomycin—melanoma	0.000268	0.00142	CcSEcCtD
Fluvoxamine—Liver function test abnormal—Docetaxel—melanoma	0.000267	0.00141	CcSEcCtD
Fluvoxamine—Vomiting—Vemurafenib—melanoma	0.000266	0.00141	CcSEcCtD
Fluvoxamine—Alopecia—Temozolomide—melanoma	0.000266	0.00141	CcSEcCtD
Fluvoxamine—Dry skin—Docetaxel—melanoma	0.000265	0.0014	CcSEcCtD
Fluvoxamine—Myalgia—Bleomycin—melanoma	0.000265	0.0014	CcSEcCtD
Fluvoxamine—Chest pain—Bleomycin—melanoma	0.000265	0.0014	CcSEcCtD
Fluvoxamine—Orthostatic hypotension—Docetaxel—melanoma	0.000265	0.0014	CcSEcCtD
Fluvoxamine—Rash—Vemurafenib—melanoma	0.000264	0.0014	CcSEcCtD
Fluvoxamine—Mental disorder—Temozolomide—melanoma	0.000264	0.00139	CcSEcCtD
Fluvoxamine—Dermatitis—Vemurafenib—melanoma	0.000264	0.00139	CcSEcCtD
Fluvoxamine—Back pain—Carmustine—melanoma	0.000263	0.00139	CcSEcCtD
Fluvoxamine—Headache—Vemurafenib—melanoma	0.000262	0.00139	CcSEcCtD
Fluvoxamine—Malnutrition—Temozolomide—melanoma	0.000262	0.00139	CcSEcCtD
Fluvoxamine—Breast disorder—Docetaxel—melanoma	0.000262	0.00138	CcSEcCtD
Fluvoxamine—Discomfort—Bleomycin—melanoma	0.000262	0.00138	CcSEcCtD
Fluvoxamine—Malaise—Dactinomycin—melanoma	0.000261	0.00138	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000261	0.00138	CcSEcCtD
Fluvoxamine—Leukopenia—Dactinomycin—melanoma	0.00026	0.00137	CcSEcCtD
Fluvoxamine—Dysgeusia—Temozolomide—melanoma	0.000257	0.00136	CcSEcCtD
Fluvoxamine—Confusional state—Bleomycin—melanoma	0.000256	0.00135	CcSEcCtD
Fluvoxamine—Vision blurred—Carmustine—melanoma	0.000256	0.00135	CcSEcCtD
Fluvoxamine—Tremor—Carmustine—melanoma	0.000254	0.00134	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Bleomycin—melanoma	0.000254	0.00134	CcSEcCtD
Fluvoxamine—Oedema—Bleomycin—melanoma	0.000254	0.00134	CcSEcCtD
Fluvoxamine—Back pain—Temozolomide—melanoma	0.000254	0.00134	CcSEcCtD
Fluvoxamine—Infection—Bleomycin—melanoma	0.000252	0.00133	CcSEcCtD
Fluvoxamine—Anaemia—Carmustine—melanoma	0.000251	0.00133	CcSEcCtD
Fluvoxamine—Dysphagia—Docetaxel—melanoma	0.00025	0.00132	CcSEcCtD
Fluvoxamine—Agitation—Carmustine—melanoma	0.000249	0.00132	CcSEcCtD
Fluvoxamine—Nausea—Vemurafenib—melanoma	0.000249	0.00131	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Bleomycin—melanoma	0.000248	0.00131	CcSEcCtD
Fluvoxamine—Vision blurred—Temozolomide—melanoma	0.000247	0.00131	CcSEcCtD
Fluvoxamine—Myalgia—Dactinomycin—melanoma	0.000247	0.0013	CcSEcCtD
Fluvoxamine—Tremor—Temozolomide—melanoma	0.000246	0.0013	CcSEcCtD
Fluvoxamine—Discomfort—Dactinomycin—melanoma	0.000244	0.00129	CcSEcCtD
Fluvoxamine—Angina pectoris—Docetaxel—melanoma	0.000244	0.00129	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Temozolomide—melanoma	0.000243	0.00129	CcSEcCtD
Fluvoxamine—Leukopenia—Carmustine—melanoma	0.000243	0.00128	CcSEcCtD
Fluvoxamine—Anaemia—Temozolomide—melanoma	0.000242	0.00128	CcSEcCtD
Fluvoxamine—Anorexia—Bleomycin—melanoma	0.000242	0.00128	CcSEcCtD
Fluvoxamine—Agitation—Temozolomide—melanoma	0.000241	0.00127	CcSEcCtD
Fluvoxamine—Angioedema—Temozolomide—melanoma	0.00024	0.00127	CcSEcCtD
Fluvoxamine—Hypotension—Bleomycin—melanoma	0.000237	0.00125	CcSEcCtD
Fluvoxamine—Oedema—Dactinomycin—melanoma	0.000237	0.00125	CcSEcCtD
Fluvoxamine—Malaise—Temozolomide—melanoma	0.000237	0.00125	CcSEcCtD
Fluvoxamine—Vertigo—Temozolomide—melanoma	0.000236	0.00125	CcSEcCtD
Fluvoxamine—Convulsion—Carmustine—melanoma	0.000235	0.00124	CcSEcCtD
Fluvoxamine—Infection—Dactinomycin—melanoma	0.000235	0.00124	CcSEcCtD
Fluvoxamine—Leukopenia—Temozolomide—melanoma	0.000235	0.00124	CcSEcCtD
Fluvoxamine—Hypertension—Carmustine—melanoma	0.000234	0.00124	CcSEcCtD
Fluvoxamine—Palpitations—Temozolomide—melanoma	0.000232	0.00122	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Dactinomycin—melanoma	0.000232	0.00122	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000231	0.00122	CcSEcCtD
Fluvoxamine—Chest pain—Carmustine—melanoma	0.000231	0.00122	CcSEcCtD
Fluvoxamine—Myalgia—Carmustine—melanoma	0.000231	0.00122	CcSEcCtD
Fluvoxamine—Anxiety—Carmustine—melanoma	0.00023	0.00122	CcSEcCtD
Fluvoxamine—Cough—Temozolomide—melanoma	0.000229	0.00121	CcSEcCtD
Fluvoxamine—Paraesthesia—Bleomycin—melanoma	0.000228	0.0012	CcSEcCtD
Fluvoxamine—Weight increased—Docetaxel—melanoma	0.000228	0.0012	CcSEcCtD
Fluvoxamine—Convulsion—Temozolomide—melanoma	0.000227	0.0012	CcSEcCtD
Fluvoxamine—Weight decreased—Docetaxel—melanoma	0.000226	0.0012	CcSEcCtD
Fluvoxamine—Hypertension—Temozolomide—melanoma	0.000226	0.0012	CcSEcCtD
Fluvoxamine—Dyspnoea—Bleomycin—melanoma	0.000226	0.0012	CcSEcCtD
Fluvoxamine—Anorexia—Dactinomycin—melanoma	0.000226	0.00119	CcSEcCtD
Fluvoxamine—Pneumonia—Docetaxel—melanoma	0.000224	0.00119	CcSEcCtD
Fluvoxamine—Confusional state—Carmustine—melanoma	0.000223	0.00118	CcSEcCtD
Fluvoxamine—Myalgia—Temozolomide—melanoma	0.000223	0.00118	CcSEcCtD
Fluvoxamine—Arthralgia—Temozolomide—melanoma	0.000223	0.00118	CcSEcCtD
Fluvoxamine—Anxiety—Temozolomide—melanoma	0.000223	0.00118	CcSEcCtD
Fluvoxamine—Oedema—Carmustine—melanoma	0.000221	0.00117	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000221	0.00117	CcSEcCtD
Fluvoxamine—Discomfort—Temozolomide—melanoma	0.000221	0.00117	CcSEcCtD
Fluvoxamine—Decreased appetite—Bleomycin—melanoma	0.000221	0.00117	CcSEcCtD
Fluvoxamine—Infection—Carmustine—melanoma	0.00022	0.00116	CcSEcCtD
Fluvoxamine—Acute coronary syndrome—Docetaxel—melanoma	0.00022	0.00116	CcSEcCtD
Fluvoxamine—Renal failure—Docetaxel—melanoma	0.000219	0.00116	CcSEcCtD
Fluvoxamine—Myocardial infarction—Docetaxel—melanoma	0.000219	0.00116	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Docetaxel—melanoma	0.000219	0.00116	CcSEcCtD
Fluvoxamine—Dry mouth—Temozolomide—melanoma	0.000218	0.00115	CcSEcCtD
Fluvoxamine—Stomatitis—Docetaxel—melanoma	0.000218	0.00115	CcSEcCtD
Fluvoxamine—Jaundice—Docetaxel—melanoma	0.000218	0.00115	CcSEcCtD
Fluvoxamine—Pain—Bleomycin—melanoma	0.000217	0.00115	CcSEcCtD
Fluvoxamine—Conjunctivitis—Docetaxel—melanoma	0.000217	0.00115	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Carmustine—melanoma	0.000217	0.00115	CcSEcCtD
Fluvoxamine—Tachycardia—Carmustine—melanoma	0.000216	0.00114	CcSEcCtD
Fluvoxamine—Confusional state—Temozolomide—melanoma	0.000216	0.00114	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000216	0.00114	CcSEcCtD
Fluvoxamine—Oedema—Temozolomide—melanoma	0.000214	0.00113	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Temozolomide—melanoma	0.000214	0.00113	CcSEcCtD
Fluvoxamine—Infection—Temozolomide—melanoma	0.000213	0.00112	CcSEcCtD
Fluvoxamine—Anorexia—Carmustine—melanoma	0.000211	0.00112	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Docetaxel—melanoma	0.000211	0.00112	CcSEcCtD
Fluvoxamine—Epistaxis—Docetaxel—melanoma	0.000211	0.00111	CcSEcCtD
Fluvoxamine—Nervous system disorder—Temozolomide—melanoma	0.00021	0.00111	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Temozolomide—melanoma	0.00021	0.00111	CcSEcCtD
Fluvoxamine—Feeling abnormal—Bleomycin—melanoma	0.000209	0.00111	CcSEcCtD
Fluvoxamine—Agranulocytosis—Docetaxel—melanoma	0.000208	0.0011	CcSEcCtD
Fluvoxamine—Hypotension—Carmustine—melanoma	0.000207	0.00109	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Temozolomide—melanoma	0.000207	0.00109	CcSEcCtD
Fluvoxamine—Decreased appetite—Dactinomycin—melanoma	0.000206	0.00109	CcSEcCtD
Fluvoxamine—Fatigue—Dactinomycin—melanoma	0.000204	0.00108	CcSEcCtD
Fluvoxamine—Anorexia—Temozolomide—melanoma	0.000204	0.00108	CcSEcCtD
Fluvoxamine—Pain—Dactinomycin—melanoma	0.000202	0.00107	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Carmustine—melanoma	0.000202	0.00107	CcSEcCtD
Fluvoxamine—Urticaria—Bleomycin—melanoma	0.000202	0.00107	CcSEcCtD
Fluvoxamine—Haemoglobin—Docetaxel—melanoma	0.000201	0.00106	CcSEcCtD
Fluvoxamine—Rhinitis—Docetaxel—melanoma	0.000201	0.00106	CcSEcCtD
Fluvoxamine—Body temperature increased—Bleomycin—melanoma	0.000201	0.00106	CcSEcCtD
Fluvoxamine—Haemorrhage—Docetaxel—melanoma	0.0002	0.00106	CcSEcCtD
Fluvoxamine—Hepatitis—Docetaxel—melanoma	0.0002	0.00106	CcSEcCtD
Fluvoxamine—Insomnia—Carmustine—melanoma	0.0002	0.00106	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Docetaxel—melanoma	0.000199	0.00105	CcSEcCtD
Fluvoxamine—Paraesthesia—Carmustine—melanoma	0.000199	0.00105	CcSEcCtD
Fluvoxamine—Pharyngitis—Docetaxel—melanoma	0.000199	0.00105	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Docetaxel—melanoma	0.000198	0.00105	CcSEcCtD
Fluvoxamine—Dyspnoea—Carmustine—melanoma	0.000197	0.00104	CcSEcCtD
Fluvoxamine—Oedema peripheral—Docetaxel—melanoma	0.000197	0.00104	CcSEcCtD
Fluvoxamine—Somnolence—Carmustine—melanoma	0.000197	0.00104	CcSEcCtD
Fluvoxamine—Urethral disorder—Docetaxel—melanoma	0.000196	0.00104	CcSEcCtD
Fluvoxamine—Feeling abnormal—Dactinomycin—melanoma	0.000195	0.00103	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000195	0.00103	CcSEcCtD
Fluvoxamine—Insomnia—Temozolomide—melanoma	0.000194	0.00102	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Dactinomycin—melanoma	0.000194	0.00102	CcSEcCtD
Fluvoxamine—Visual impairment—Docetaxel—melanoma	0.000193	0.00102	CcSEcCtD
Fluvoxamine—Decreased appetite—Carmustine—melanoma	0.000193	0.00102	CcSEcCtD
Fluvoxamine—Paraesthesia—Temozolomide—melanoma	0.000192	0.00102	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Carmustine—melanoma	0.000191	0.00101	CcSEcCtD
Fluvoxamine—Dyspnoea—Temozolomide—melanoma	0.000191	0.00101	CcSEcCtD
Fluvoxamine—Somnolence—Temozolomide—melanoma	0.00019	0.00101	CcSEcCtD
Fluvoxamine—Erythema multiforme—Docetaxel—melanoma	0.000189	0.001	CcSEcCtD
Fluvoxamine—Constipation—Carmustine—melanoma	0.000189	0.001	CcSEcCtD
Fluvoxamine—Pain—Carmustine—melanoma	0.000189	0.001	CcSEcCtD
Fluvoxamine—Dyspepsia—Temozolomide—melanoma	0.000188	0.000996	CcSEcCtD
Fluvoxamine—Eye disorder—Docetaxel—melanoma	0.000187	0.00099	CcSEcCtD
Fluvoxamine—Abdominal pain—Dactinomycin—melanoma	0.000187	0.000989	CcSEcCtD
Fluvoxamine—Body temperature increased—Dactinomycin—melanoma	0.000187	0.000989	CcSEcCtD
Fluvoxamine—Hypersensitivity—Bleomycin—melanoma	0.000187	0.000988	CcSEcCtD
Fluvoxamine—Decreased appetite—Temozolomide—melanoma	0.000186	0.000983	CcSEcCtD
Fluvoxamine—Cardiac disorder—Docetaxel—melanoma	0.000186	0.000983	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Temozolomide—melanoma	0.000185	0.000977	CcSEcCtD
Fluvoxamine—Fatigue—Temozolomide—melanoma	0.000185	0.000975	CcSEcCtD
Fluvoxamine—Constipation—Temozolomide—melanoma	0.000183	0.000967	CcSEcCtD
Fluvoxamine—Pain—Temozolomide—melanoma	0.000183	0.000967	CcSEcCtD
Fluvoxamine—Feeling abnormal—Carmustine—melanoma	0.000183	0.000965	CcSEcCtD
Fluvoxamine—Asthenia—Bleomycin—melanoma	0.000182	0.000962	CcSEcCtD
Fluvoxamine—Angiopathy—Docetaxel—melanoma	0.000182	0.000961	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Carmustine—melanoma	0.000181	0.000957	CcSEcCtD
Fluvoxamine—Chills—Docetaxel—melanoma	0.00018	0.00095	CcSEcCtD
Fluvoxamine—Pruritus—Bleomycin—melanoma	0.00018	0.000949	CcSEcCtD
Fluvoxamine—Arrhythmia—Docetaxel—melanoma	0.000179	0.000946	CcSEcCtD
Fluvoxamine—Alopecia—Docetaxel—melanoma	0.000177	0.000936	CcSEcCtD
Fluvoxamine—Feeling abnormal—Temozolomide—melanoma	0.000176	0.000932	CcSEcCtD
Fluvoxamine—Mental disorder—Docetaxel—melanoma	0.000176	0.000928	CcSEcCtD
Fluvoxamine—Body temperature increased—Carmustine—melanoma	0.000175	0.000925	CcSEcCtD
Fluvoxamine—Abdominal pain—Carmustine—melanoma	0.000175	0.000925	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Temozolomide—melanoma	0.000175	0.000925	CcSEcCtD
Fluvoxamine—Malnutrition—Docetaxel—melanoma	0.000174	0.000922	CcSEcCtD
Fluvoxamine—Hypersensitivity—Dactinomycin—melanoma	0.000174	0.000921	CcSEcCtD
Fluvoxamine—Dysgeusia—Docetaxel—melanoma	0.000171	0.000903	CcSEcCtD
Fluvoxamine—Urticaria—Temozolomide—melanoma	0.00017	0.000899	CcSEcCtD
Fluvoxamine—Asthenia—Dactinomycin—melanoma	0.00017	0.000897	CcSEcCtD
Fluvoxamine—Body temperature increased—Temozolomide—melanoma	0.000169	0.000894	CcSEcCtD
Fluvoxamine—Abdominal pain—Temozolomide—melanoma	0.000169	0.000894	CcSEcCtD
Fluvoxamine—Back pain—Docetaxel—melanoma	0.000169	0.000892	CcSEcCtD
Fluvoxamine—Muscle spasms—Docetaxel—melanoma	0.000168	0.000886	CcSEcCtD
Fluvoxamine—Hypersensitivity—Carmustine—melanoma	0.000163	0.000862	CcSEcCtD
Fluvoxamine—Diarrhoea—Dactinomycin—melanoma	0.000162	0.000856	CcSEcCtD
Fluvoxamine—Vomiting—Bleomycin—melanoma	0.000161	0.000853	CcSEcCtD
Fluvoxamine—Anaemia—Docetaxel—melanoma	0.000161	0.000852	CcSEcCtD
Fluvoxamine—Rash—Bleomycin—melanoma	0.00016	0.000846	CcSEcCtD
Fluvoxamine—Dermatitis—Bleomycin—melanoma	0.00016	0.000845	CcSEcCtD
Fluvoxamine—Asthenia—Carmustine—melanoma	0.000159	0.00084	CcSEcCtD
Fluvoxamine—Hypersensitivity—Temozolomide—melanoma	0.000158	0.000833	CcSEcCtD
Fluvoxamine—Syncope—Docetaxel—melanoma	0.000156	0.000827	CcSEcCtD
Fluvoxamine—Leukopenia—Docetaxel—melanoma	0.000156	0.000825	CcSEcCtD
Fluvoxamine—Palpitations—Docetaxel—melanoma	0.000154	0.000815	CcSEcCtD
Fluvoxamine—Asthenia—Temozolomide—melanoma	0.000154	0.000812	CcSEcCtD
Fluvoxamine—Loss of consciousness—Docetaxel—melanoma	0.000153	0.00081	CcSEcCtD
Fluvoxamine—Cough—Docetaxel—melanoma	0.000152	0.000804	CcSEcCtD
Fluvoxamine—Diarrhoea—Carmustine—melanoma	0.000152	0.000801	CcSEcCtD
Fluvoxamine—Pruritus—Temozolomide—melanoma	0.000151	0.0008	CcSEcCtD
Fluvoxamine—Convulsion—Docetaxel—melanoma	0.000151	0.000799	CcSEcCtD
Fluvoxamine—Nausea—Bleomycin—melanoma	0.000151	0.000797	CcSEcCtD
Fluvoxamine—Hypertension—Docetaxel—melanoma	0.000151	0.000796	CcSEcCtD
Fluvoxamine—Vomiting—Dactinomycin—melanoma	0.00015	0.000795	CcSEcCtD
Fluvoxamine—Rash—Dactinomycin—melanoma	0.000149	0.000789	CcSEcCtD
Fluvoxamine—Arthralgia—Docetaxel—melanoma	0.000148	0.000785	CcSEcCtD
Fluvoxamine—Chest pain—Docetaxel—melanoma	0.000148	0.000785	CcSEcCtD
Fluvoxamine—Myalgia—Docetaxel—melanoma	0.000148	0.000785	CcSEcCtD
Fluvoxamine—Dizziness—Carmustine—melanoma	0.000146	0.000774	CcSEcCtD
Fluvoxamine—Diarrhoea—Temozolomide—melanoma	0.000146	0.000774	CcSEcCtD
Fluvoxamine—Dry mouth—Docetaxel—melanoma	0.000145	0.000767	CcSEcCtD
Fluvoxamine—Confusional state—Docetaxel—melanoma	0.000144	0.000759	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Docetaxel—melanoma	0.000142	0.000752	CcSEcCtD
Fluvoxamine—Oedema—Docetaxel—melanoma	0.000142	0.000752	CcSEcCtD
Fluvoxamine—Dizziness—Temozolomide—melanoma	0.000142	0.000748	CcSEcCtD
Fluvoxamine—Infection—Docetaxel—melanoma	0.000141	0.000747	CcSEcCtD
Fluvoxamine—Vomiting—Carmustine—melanoma	0.000141	0.000744	CcSEcCtD
Fluvoxamine—Nausea—Dactinomycin—melanoma	0.000141	0.000743	CcSEcCtD
Fluvoxamine—Shock—Docetaxel—melanoma	0.00014	0.00074	CcSEcCtD
Fluvoxamine—Rash—Carmustine—melanoma	0.00014	0.000738	CcSEcCtD
Fluvoxamine—Nervous system disorder—Docetaxel—melanoma	0.00014	0.000738	CcSEcCtD
Fluvoxamine—Dermatitis—Carmustine—melanoma	0.00014	0.000737	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Docetaxel—melanoma	0.000139	0.000737	CcSEcCtD
Fluvoxamine—Tachycardia—Docetaxel—melanoma	0.000139	0.000734	CcSEcCtD
Fluvoxamine—Headache—Carmustine—melanoma	0.000139	0.000733	CcSEcCtD
Fluvoxamine—Vomiting—Temozolomide—melanoma	0.000136	0.000719	CcSEcCtD
Fluvoxamine—Anorexia—Docetaxel—melanoma	0.000136	0.000717	CcSEcCtD
Fluvoxamine—Rash—Temozolomide—melanoma	0.000135	0.000713	CcSEcCtD
Fluvoxamine—Dermatitis—Temozolomide—melanoma	0.000135	0.000713	CcSEcCtD
Fluvoxamine—Headache—Temozolomide—melanoma	0.000134	0.000709	CcSEcCtD
Fluvoxamine—Hypotension—Docetaxel—melanoma	0.000133	0.000703	CcSEcCtD
Fluvoxamine—Nausea—Carmustine—melanoma	0.000132	0.000695	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Docetaxel—melanoma	0.00013	0.000685	CcSEcCtD
Fluvoxamine—Insomnia—Docetaxel—melanoma	0.000129	0.00068	CcSEcCtD
Fluvoxamine—Paraesthesia—Docetaxel—melanoma	0.000128	0.000676	CcSEcCtD
Fluvoxamine—Nausea—Temozolomide—melanoma	0.000127	0.000672	CcSEcCtD
Fluvoxamine—Dyspnoea—Docetaxel—melanoma	0.000127	0.000671	CcSEcCtD
Fluvoxamine—Somnolence—Docetaxel—melanoma	0.000127	0.000669	CcSEcCtD
Fluvoxamine—Dyspepsia—Docetaxel—melanoma	0.000125	0.000662	CcSEcCtD
Fluvoxamine—Decreased appetite—Docetaxel—melanoma	0.000124	0.000654	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Docetaxel—melanoma	0.000123	0.000649	CcSEcCtD
Fluvoxamine—Fatigue—Docetaxel—melanoma	0.000123	0.000649	CcSEcCtD
Fluvoxamine—Constipation—Docetaxel—melanoma	0.000122	0.000643	CcSEcCtD
Fluvoxamine—Pain—Docetaxel—melanoma	0.000122	0.000643	CcSEcCtD
Fluvoxamine—Feeling abnormal—Docetaxel—melanoma	0.000117	0.00062	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Docetaxel—melanoma	0.000116	0.000615	CcSEcCtD
Fluvoxamine—Body temperature increased—Docetaxel—melanoma	0.000113	0.000595	CcSEcCtD
Fluvoxamine—Abdominal pain—Docetaxel—melanoma	0.000113	0.000595	CcSEcCtD
Fluvoxamine—Hypersensitivity—Docetaxel—melanoma	0.000105	0.000554	CcSEcCtD
Fluvoxamine—Asthenia—Docetaxel—melanoma	0.000102	0.00054	CcSEcCtD
Fluvoxamine—Pruritus—Docetaxel—melanoma	0.000101	0.000532	CcSEcCtD
Fluvoxamine—Diarrhoea—Docetaxel—melanoma	9.74e-05	0.000515	CcSEcCtD
Fluvoxamine—Dizziness—Docetaxel—melanoma	9.41e-05	0.000497	CcSEcCtD
Fluvoxamine—Vomiting—Docetaxel—melanoma	9.05e-05	0.000478	CcSEcCtD
Fluvoxamine—Rash—Docetaxel—melanoma	8.98e-05	0.000474	CcSEcCtD
Fluvoxamine—Dermatitis—Docetaxel—melanoma	8.97e-05	0.000474	CcSEcCtD
Fluvoxamine—Headache—Docetaxel—melanoma	8.92e-05	0.000471	CcSEcCtD
Fluvoxamine—Nausea—Docetaxel—melanoma	8.46e-05	0.000447	CcSEcCtD
Fluvoxamine—CYP2B6—Metabolism—FASN—melanoma	9.62e-06	0.000175	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP17A1—melanoma	9.61e-06	0.000175	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GNA11—melanoma	9.61e-06	0.000175	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PLA2G6—melanoma	9.55e-06	0.000173	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GPAM—melanoma	9.51e-06	0.000173	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.48e-06	0.000172	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PLA2G6—melanoma	9.46e-06	0.000172	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—SLC5A5—melanoma	9.46e-06	0.000172	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—FASN—melanoma	9.42e-06	0.000171	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC6A11—melanoma	9.4e-06	0.000171	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIP4K2A—melanoma	9.4e-06	0.000171	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—FASN—melanoma	9.4e-06	0.000171	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	9.36e-06	0.00017	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—VCAN—melanoma	9.32e-06	0.000169	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	9.32e-06	0.000169	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—SLC5A5—melanoma	9.27e-06	0.000168	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—SLC5A5—melanoma	9.25e-06	0.000168	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTAP—melanoma	9.15e-06	0.000166	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GNAQ—melanoma	9.14e-06	0.000166	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CD44—melanoma	9.14e-06	0.000166	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—VCAN—melanoma	9.1e-06	0.000165	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GNA11—melanoma	9.08e-06	0.000165	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PRKCA—melanoma	8.98e-06	0.000163	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GNAQ—melanoma	8.95e-06	0.000163	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CD44—melanoma	8.95e-06	0.000163	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GNAQ—melanoma	8.93e-06	0.000162	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CD44—melanoma	8.93e-06	0.000162	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ERCC2—melanoma	8.9e-06	0.000162	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—FASN—melanoma	8.88e-06	0.000161	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.82e-06	0.00016	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP1B1—melanoma	8.76e-06	0.000159	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—SLC5A5—melanoma	8.74e-06	0.000159	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP1B1—melanoma	8.58e-06	0.000156	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—VCAN—melanoma	8.57e-06	0.000156	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP1B1—melanoma	8.56e-06	0.000156	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.52e-06	0.000155	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—VCAN—melanoma	8.5e-06	0.000154	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GNAQ—melanoma	8.44e-06	0.000153	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CD44—melanoma	8.44e-06	0.000153	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.26e-06	0.00015	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.19e-06	0.000149	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LUM—melanoma	8.15e-06	0.000148	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PHGDH—melanoma	8.15e-06	0.000148	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP1B1—melanoma	8.09e-06	0.000147	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PLA2G6—melanoma	8.09e-06	0.000147	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.05e-06	0.000146	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HPSE—melanoma	7.99e-06	0.000145	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	7.87e-06	0.000143	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP17A1—melanoma	7.87e-06	0.000143	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CUBN—melanoma	7.85e-06	0.000143	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.77e-06	0.000141	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.76e-06	0.000141	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP17A1—melanoma	7.68e-06	0.000139	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	7.66e-06	0.000139	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SDHD—melanoma	7.58e-06	0.000138	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CSPG4—melanoma	7.58e-06	0.000138	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—BSG—melanoma	7.58e-06	0.000138	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GNA11—melanoma	7.43e-06	0.000135	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GPAM—melanoma	7.34e-06	0.000133	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—FASN—melanoma	7.27e-06	0.000132	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—VCAN—melanoma	7.26e-06	0.000132	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GNA11—melanoma	7.25e-06	0.000132	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP17A1—melanoma	7.23e-06	0.000131	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ABCB1—melanoma	7.21e-06	0.000131	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP17A1—melanoma	7.17e-06	0.00013	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—SLC5A5—melanoma	7.15e-06	0.00013	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.14e-06	0.00013	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	7.11e-06	0.000129	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—FASN—melanoma	7.09e-06	0.000129	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.07e-06	0.000129	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ABCB1—melanoma	7.07e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ABCB1—melanoma	7.05e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CG—melanoma	7.03e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	6.98e-06	0.000127	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—SLC5A5—melanoma	6.98e-06	0.000127	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CD44—melanoma	6.91e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GNAQ—melanoma	6.91e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.88e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GNA11—melanoma	6.83e-06	0.000124	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PPARG—melanoma	6.79e-06	0.000123	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GNA11—melanoma	6.77e-06	0.000123	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.76e-06	0.000123	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GNAQ—melanoma	6.74e-06	0.000122	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CD44—melanoma	6.74e-06	0.000122	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.7e-06	0.000122	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—FASN—melanoma	6.69e-06	0.000121	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ABCB1—melanoma	6.66e-06	0.000121	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PRKCA—melanoma	6.64e-06	0.000121	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.64e-06	0.000121	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—FASN—melanoma	6.63e-06	0.00012	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP1B1—melanoma	6.62e-06	0.00012	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ERCC2—melanoma	6.59e-06	0.00012	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—SLC5A5—melanoma	6.58e-06	0.000119	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—SLC5A5—melanoma	6.52e-06	0.000118	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PRKCA—melanoma	6.5e-06	0.000118	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PRKCA—melanoma	6.49e-06	0.000118	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP1B1—melanoma	6.46e-06	0.000117	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ERCC2—melanoma	6.45e-06	0.000117	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ERCC2—melanoma	6.44e-06	0.000117	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GNAQ—melanoma	6.35e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CD44—melanoma	6.35e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GNAQ—melanoma	6.3e-06	0.000114	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CD44—melanoma	6.3e-06	0.000114	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PLA2G6—melanoma	6.24e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CD—melanoma	6.18e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.17e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PRKCA—melanoma	6.13e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP17A1—melanoma	6.13e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.11e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ALB—melanoma	6.1e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP1B1—melanoma	6.09e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ERCC2—melanoma	6.08e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.04e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP1B1—melanoma	6.04e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	5.97e-06	0.000108	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.84e-06	0.000106	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GNA11—melanoma	5.79e-06	0.000105	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—FASN—melanoma	5.66e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—VCAN—melanoma	5.61e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC5A5—melanoma	5.57e-06	0.000101	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ABCB1—melanoma	5.45e-06	9.91e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CB—melanoma	5.39e-06	9.79e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CD44—melanoma	5.38e-06	9.78e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GNAQ—melanoma	5.38e-06	9.78e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGS2—melanoma	5.34e-06	9.7e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.33e-06	9.68e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.27e-06	9.57e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.22e-06	9.49e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CG—melanoma	5.2e-06	9.45e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP1B1—melanoma	5.16e-06	9.37e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CG—melanoma	5.09e-06	9.26e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CG—melanoma	5.08e-06	9.24e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.04e-06	9.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPARG—melanoma	5.02e-06	9.12e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PRKCA—melanoma	5.02e-06	9.12e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ABCB1—melanoma	5.01e-06	9.11e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ERCC2—melanoma	4.98e-06	9.04e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ABCB1—melanoma	4.97e-06	9.03e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPARG—melanoma	4.92e-06	8.93e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPARG—melanoma	4.91e-06	8.91e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PRKCA—melanoma	4.9e-06	8.9e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ERCC2—melanoma	4.86e-06	8.82e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CG—melanoma	4.8e-06	8.73e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP17A1—melanoma	4.73e-06	8.59e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTEN—melanoma	4.66e-06	8.46e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPARG—melanoma	4.64e-06	8.42e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PRKCA—melanoma	4.61e-06	8.38e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ERCC2—melanoma	4.58e-06	8.32e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PRKCA—melanoma	4.58e-06	8.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CD—melanoma	4.57e-06	8.31e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.55e-06	8.27e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ERCC2—melanoma	4.54e-06	8.24e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ALB—melanoma	4.51e-06	8.2e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CD—melanoma	4.48e-06	8.14e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CD—melanoma	4.47e-06	8.12e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GNA11—melanoma	4.47e-06	8.12e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ALB—melanoma	4.42e-06	8.03e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ALB—melanoma	4.41e-06	8.02e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—FASN—melanoma	4.37e-06	7.94e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC5A5—melanoma	4.3e-06	7.81e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ABCB1—melanoma	4.25e-06	7.72e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CD—melanoma	4.22e-06	7.67e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ALB—melanoma	4.17e-06	7.57e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CD44—melanoma	4.15e-06	7.54e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GNAQ—melanoma	4.15e-06	7.54e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.12e-06	7.49e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CB—melanoma	3.99e-06	7.24e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP1B1—melanoma	3.98e-06	7.23e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS2—melanoma	3.95e-06	7.17e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CG—melanoma	3.93e-06	7.14e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PRKCA—melanoma	3.91e-06	7.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CB—melanoma	3.9e-06	7.09e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CB—melanoma	3.9e-06	7.08e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ERCC2—melanoma	3.88e-06	7.04e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS2—melanoma	3.87e-06	7.03e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS2—melanoma	3.86e-06	7.01e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CG—melanoma	3.84e-06	6.97e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARG—melanoma	3.79e-06	6.89e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.76e-06	6.83e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARG—melanoma	3.7e-06	6.73e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CB—melanoma	3.68e-06	6.69e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS2—melanoma	3.65e-06	6.63e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CG—melanoma	3.61e-06	6.57e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CG—melanoma	3.58e-06	6.51e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARG—melanoma	3.49e-06	6.34e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARG—melanoma	3.46e-06	6.28e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CD—melanoma	3.45e-06	6.28e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTEN—melanoma	3.44e-06	6.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ALB—melanoma	3.41e-06	6.2e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTEN—melanoma	3.37e-06	6.13e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CD—melanoma	3.37e-06	6.13e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTEN—melanoma	3.37e-06	6.12e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ALB—melanoma	3.33e-06	6.05e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CA—melanoma	3.28e-06	5.97e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ABCB1—melanoma	3.28e-06	5.96e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.21e-06	5.84e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTEN—melanoma	3.18e-06	5.78e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CD—melanoma	3.18e-06	5.77e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CD—melanoma	3.15e-06	5.72e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ALB—melanoma	3.14e-06	5.7e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALB—melanoma	3.11e-06	5.65e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CG—melanoma	3.06e-06	5.56e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PRKCA—melanoma	3.02e-06	5.48e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CB—melanoma	3.01e-06	5.47e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ERCC2—melanoma	2.99e-06	5.44e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS2—melanoma	2.98e-06	5.42e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARG—melanoma	2.96e-06	5.37e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CB—melanoma	2.94e-06	5.34e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS2—melanoma	2.91e-06	5.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CB—melanoma	2.77e-06	5.03e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CB—melanoma	2.75e-06	4.99e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS2—melanoma	2.74e-06	4.99e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS2—melanoma	2.72e-06	4.94e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CD—melanoma	2.69e-06	4.89e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKT1—melanoma	2.68e-06	4.88e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALB—melanoma	2.66e-06	4.83e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTEN—melanoma	2.6e-06	4.73e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTEN—melanoma	2.54e-06	4.61e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CA—melanoma	2.43e-06	4.41e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTEN—melanoma	2.39e-06	4.35e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CA—melanoma	2.38e-06	4.32e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CA—melanoma	2.37e-06	4.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTEN—melanoma	2.37e-06	4.31e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CG—melanoma	2.36e-06	4.29e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CB—melanoma	2.35e-06	4.26e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS2—melanoma	2.32e-06	4.22e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARG—melanoma	2.28e-06	4.14e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CA—melanoma	2.24e-06	4.08e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CD—melanoma	2.08e-06	3.77e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALB—melanoma	2.05e-06	3.73e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTEN—melanoma	2.03e-06	3.68e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKT1—melanoma	1.98e-06	3.61e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKT1—melanoma	1.94e-06	3.53e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKT1—melanoma	1.94e-06	3.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CA—melanoma	1.84e-06	3.34e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKT1—melanoma	1.83e-06	3.33e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CB—melanoma	1.81e-06	3.29e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS2—melanoma	1.79e-06	3.26e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CA—melanoma	1.79e-06	3.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CA—melanoma	1.69e-06	3.07e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CA—melanoma	1.67e-06	3.04e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTEN—melanoma	1.56e-06	2.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKT1—melanoma	1.5e-06	2.72e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKT1—melanoma	1.46e-06	2.66e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CA—melanoma	1.43e-06	2.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKT1—melanoma	1.38e-06	2.51e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKT1—melanoma	1.37e-06	2.48e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKT1—melanoma	1.17e-06	2.12e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CA—melanoma	1.1e-06	2.01e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKT1—melanoma	9.02e-07	1.64e-05	CbGpPWpGaD
